Editorial overview - Ethnic variation in drug response: Implications for the development and regulation of drugs

Current Opinion in Drug Discovery and Development

Volumn 11, Issue 1, 2008, Pages 29-31

  Johnson, D E ^a,b   Park, K ^c   Smith, D A ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Emiliem Inc   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOCHROME P450 2C19; CYTOCHROME P450 2D6; GEFITINIB; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TACRINE; DRUG;

DRUG METABOLISM; DRUG RESPONSE; EDITORIAL; ETHNIC DIFFERENCE; ETHNICITY; HUMAN; DRUG DESIGN; DRUG LEGISLATION; ETHNIC GROUP; GENE FREQUENCY; METABOLISM; PHARMACOLOGY; PHENOTYPE;

DRUG DESIGN; ETHNIC GROUPS; GENE FREQUENCY; HUMANS; LEGISLATION, DRUG; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGY; PHENOTYPE;

EID: 37849010073     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (0)